Fachrepositorium Lebenswissenschaften

Wegen Wartungsarbeiten kann die Erreichbarkeit des Fachrepositorium am 26. September 2025 eingeschränkt sein.

7 Treffer

Suche

Publisso-Menue

Semi-mechanistic population pharmacokinetic modeling of DZIF-10c, a neutralizing antibody against SARS-Cov-2: predicting systemic and lung exposure following inhaled and intravenous administration

2024 . Kurup, Sree | de Mendizabal, Nieves Velez | Becker, Stephan | Bolella, Erica | De Sousa, Dorothy | Fätkenheuer, Gerd | Gruell, Henning | Klein, Florian | Malin, Jakob J | Schmid, Ulrike | Korell, Julia

Results of the Cologne Corona Surveillance (CoCoS) study – a cross-sectional study: survey data on risk factors of SARS-CoV-2 infection in adults

2023 . Oberste, Max | Schnörch, Nadja | Shah-Hosseini, Kija | Asenova, Teodora | Dewald, Felix | Lehmann, Clara | Buess, Michael | Fätkenheuer, Gerd | Klein, Florian | Rosenberger, Kerstin Daniela | Kossow, Annelene | Neuhann, Florian | Hellmich, Martin

Results of the Cologne Corona surveillance (CoCoS) study – a prospective population-based cohort study: incidence data and potential underestimation of new SARS-CoV-2 adult infections by health authorities

SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia

Protocol of the Cologne Corona Surveillance (CoCoS) Study– a prospective population-based cohort study

2021 . Oberste, Max | Pusch, Lynn-Marie | Roth, Rebecca | Shah-Hosseini, Kija | Dewald, Felix | Müller, Claudia | Stach von Goltzheim, Luise | Lehmann, Clara | Buess, Michael | Wolff, Anna | Fätkenheuer, Gerd | Wiesmüller, Gerhard | Klein, Florian | Hellmich, Martin | Neuhann, Florian

No secret hiding place? Absence of SARS-CoV-2 on the ocular surface of 1145 hospitalized patients in a pandemic area

2021 . Rokohl, Alexander Christopher | Grajewski, Rafael S. | Wawer Matos, Philomena A. | Koch, Hannah-Leah | Dewald, Felix | Klein, Florian | Fätkenheuer, Gerd | Lehmann, Clara | Cursiefen, Claus | Heindl, Ludwig M.

Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting